Advanced Practice Midwife in Rockport, ME Accepting Medicare

8 Advanced Practice Midwife nurses found. Showing 1 - 8

Eve K Hadley, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3 Glen Cove Dr, Suite 1, Rockport, ME 04856 Phone: 207-921-8900    Fax: 207-921-5296

Marian Lynne Frey, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3 Glen Cove Dr, Rockport, ME 04856 Phone: 207-596-8900    Fax: 207-593-5296

Ms. Mary Catherine Carpenter, MSN CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3 Glen Cove Drive, Rockport, ME 04856 Phone: 207-301-8915    Fax: 207-301-5296

Erin Leigh Monberg, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3 Glen Cove Dr, Suite 1, Rockport, ME 04856 Phone: 207-921-8900    Fax: 207-921-5296

Elisabeth Walker Frederick, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3 Glen Cove Dr Ste 1, Rockport, ME 04856 Phone: 207-301-8900

Nancy K Alexander, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3 Glen Cove Dr Ste 1, Rockport, ME 04856 Phone: 207-301-8900    Fax: 207-301-5296

Clara B Buescher, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3 Glen Cove Dr, Rockport, ME 04856 Phone: 207-596-8900    Fax: 207-593-5296

Susan E Harris, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3 Glen Cove Dr, Rockport, ME 04856 Phone: 207-596-8900    Fax: 207-593-5296

News Archive

New study shows early signs of resistance among bed bugs to two commonly used insecticides

Pest management professionals battling the ongoing resurgence of bed bugs are wise to employ a well-rounded set of measures that reduces reliance on chemical control, as new research shows the early signs of resistance developing among bed bugs to two commonly used insecticides.

Enzymes are the way to a virus' 'heart'

The arrival of bluetongue virus (BTV) in the UK last year posed a major threat to the economy and the increasing temperatures of our changing climate mean it is here to stay.

Brookhaven Science Associates, BioSET receive U.S. patent for tissue regeneration technology

Brookhaven Science Associates, the company that manages the U.S. Department of Energy's Brookhaven National Laboratory, and Biosurface Engineering Technologies, Inc. of Rockville, Maryland, have been issued a U.S. patent for an improved second-generation technology for designing synthetic peptides that are important for tissue regeneration.

Transgene raises €65.5M via two-step capital increase

Transgene SA, a French biopharmaceutical company focused on discovering, developing and manufacturing targeted immunotherapies for the treatment of cancer and infectious diseases, announces that it has raised a total of €65.5 million via a two-step capital increase.

Study describes radiologic findings in H7N9 pneumonia

H7N9 pneumonia is characterized by imaging findings that differentiate it from other types of pneumonia, including rapidly progressive changes in the lungs and pulmonary connective tissues, according to the first study to describe radiologic findings in the disease. The results are published online in the journal Radiology.

Read more Medical News

› Verified 9 days ago